Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-021398)

Filing Details

Accession Number:: 0000899243-22-021398
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-07 19:39:15
Reporting Period:: 2022-06-06

Accepted Time:: 2022-06-07 19:39:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1587221	Zosano Pharma Corp	ZSAN	Pharmaceutical Preparations (2834)	454488360

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1799864	Christine Matthews	C/O Zosano Pharma Corporation 34790 Ardentech Court Fremont CA 94555	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-06-06	82	$0.71	4,183	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.